A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
- Bill Number
- S.Res. 752
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2026-05-21: Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2447)
- Last Updated
- 2026-06-10T10:56:28Z
AI-Generated Summary
Purpose
The legislation expresses Senate support for designating May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month." It aims to increase public understanding of these two rare brain disorders that worsen over time, highlight the need for research, and recognize those affected.
Key Provisions
- Outlines background on the conditions, noting they are distinct from similar diseases like Parkinson's and often lead to movement, balance, speech, swallowing, thinking, vision, and mood difficulties.
- States that about 30,000 Americans live with progressive supranuclear palsy and 2,000 with corticobasal degeneration, with most people becoming dependent on care within 3 to 4 years and facing an average lifespan of 7 to 8 years after symptoms start.
- Notes the lack of current treatments that change the disease course, common misdiagnoses, and the role of family caregivers.
- Calls for more research on causes, better support services, and education.
- Resolves that the Senate:
- Supports the May 2026 designation and its goals.
- Backs research into diagnosis, prevention, treatments, and cures.
- Recognizes the strength of affected communities.
- Commends patients, families, volunteers, healthcare workers, researchers, and groups working on these issues.
Significant Changes to Existing Law
This resolution introduces no changes to existing law. As a non-binding Senate resolution, it serves only as an expression of support without creating new legal requirements or amendments.
Potential Impacts
- On citizens: May increase awareness among patients, families, and the public, potentially leading to earlier diagnoses and better access to specialized care.
- On government agencies: Could encourage federal health agencies to prioritize related research and support programs, though no specific funding or mandates are included.
- On international relations: No direct effects anticipated.
Main Stakeholders Affected
- Individuals diagnosed with these conditions and their families.
- Caregivers and loved ones.
- Healthcare professionals and neurology specialists.
- Researchers and advocacy organizations focused on brain disorders.
Notable Legal, Constitutional, or Political Implications
No significant legal or constitutional implications exist, as the measure is symbolic and does not alter statutes or rights. Politically, it reflects bipartisan interest in health awareness issues but carries no enforcement power.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Sen. Blumenthal, Richard [D-CT]
Cosponsors (2)
Sen. Shaheen, Jeanne [D-NH], Sen. Alsobrooks, Angela D. [D-MD]
Recent Actions
- 2026-05-21: Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2447)
- 2026-05-21: Submitted in Senate
Bill Versions
- Expressing support for the designation of the month of May 2026 as Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month. — issued 2026-05-21 — PDF (3 pages)